These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of corticotherapy on mitogen induced lymphocytotoxicity in bronchial asthma. Podleski WK; Takahashi M Ann Allergy; 1978 Jun; 40(6):381-4. PubMed ID: 666058 [TBL] [Abstract][Full Text] [Related]
3. The changes of lymphocyte membrane receptors in bronchial asthma and atopic dermatitis in pediatric patients receiving treatment with polyenic fatty acids. Gorelova JYu ; Semikina EM Z Ernahrungswiss; 1998; 37 Suppl 1():142-3. PubMed ID: 9558750 [TBL] [Abstract][Full Text] [Related]
4. Suppression of mitogen-induced, cell-mediated cytotoxicity by prostaglandin F2 alpha in bronchial asthma. Podleski WK; Wardlow M Ann Allergy; 1979 Jun; 42(6):365-7. PubMed ID: 453656 [TBL] [Abstract][Full Text] [Related]
5. Kinetics of some types of lymphocytes in peripheral blood of patients with bronchial asthma. Egorova M Allergol Immunopathol (Madr); 1983; 11(6):445-50. PubMed ID: 6608257 [TBL] [Abstract][Full Text] [Related]
6. [Anomalous reaction to adenosine of lymphocytes from patients with atopic bronchial asthma. Is it a link in pathogenesis or a compensatory reaction?]. Poriadin GV; Makarkov AI; Gavrilova EV; Salmasi ZhM Biull Eksp Biol Med; 1996 Oct; 122(10):474-7. PubMed ID: 9081455 [No Abstract] [Full Text] [Related]
10. PHA-induced cytotoxicity of human lymphocytes against adherent hela cells. Huges-Law G; de Gast GC; The TH J Immunol Methods; 1978; 19(1):29-39. PubMed ID: 621405 [TBL] [Abstract][Full Text] [Related]
11. [Use of immunosuppressive drugs in bronchial asthma (author's transl)]. Szulczyńska K Przegl Lek; 1973; 30(7):578-82. PubMed ID: 4748087 [No Abstract] [Full Text] [Related]
12. [Bronchial asthma]. Bulatov PK; Uspenskaia EP Ter Arkh; 1973 Mar; 45(3):24-9. PubMed ID: 4716310 [No Abstract] [Full Text] [Related]
14. Biopharmacotherapeutic approach to bronchial asthma. Rastogi SK; Paule MG J Indian Med Assoc; 1983 Jul 1-16; 81(1-2):23-7. PubMed ID: 6139403 [No Abstract] [Full Text] [Related]
15. Inflammation and airway reactivity in asthma. Pueringer RJ; Hunninghake GW Am J Med; 1992 Jun; 92(6A):32S-38S. PubMed ID: 1352426 [TBL] [Abstract][Full Text] [Related]
16. Practical therapeutics current concepts in management of bronchial asthma. Obel AO East Afr Med J; 1981 May; 58(5):311-7. PubMed ID: 6116589 [No Abstract] [Full Text] [Related]
17. [Conditioning factors for corticotherapy of non-seasonal asthma. Usefulness of bronchial hyperreactivity]. de Barrio M; Gozalo F; Senent C; Colás C; Redondo G; Pelta R Med Clin (Barc); 1986 Mar; 86(11):450-3. PubMed ID: 3713307 [No Abstract] [Full Text] [Related]
18. The effect of ampicillin on antibody dependent (ADCC) and lectin induced (LICC) cellular cytotoxicity. Wasik M; Skopińska-Rózewska E; Swiecicka G Arch Immunol Ther Exp (Warsz); 1981; 29(3):373-7. PubMed ID: 7294973 [TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony stimulating factor and bronchial asthma--a hypothesis for novel therapeutic options. Tony JC Respir Med; 1995 Nov; 89(10):713. PubMed ID: 8570890 [No Abstract] [Full Text] [Related]
20. Interaction of interferon, macrophage, and lymphocyte tumoricidal activity with prostaglandin effect. Chirigos MA; Schultz RM; Stylos WA Ann N Y Acad Sci; 1980; 350():91-101. PubMed ID: 6165308 [No Abstract] [Full Text] [Related] [Next] [New Search]